摘要
目的了解难治性肺炎支原体肺炎(RMPP)不同时机支气管镜干预的临床疗效及安全性。方法回顾性分析2015年1月至2018年1月我院住院期间诊断RMPP患者142例,根据支气管镜干预时间,分为早期组(病程5~10 d)、中期组(病程11~15 d)、晚期组(病程≥16 d),比较3组患者临床资料。结果(1)3组患者支气管镜干预前一般资料、临床表现、炎症指标、胸部影像学积分比较差异无统计学意义。(2)早期组的住院时间、总热程、咳嗽消失时间、胸部影像学吸收时间均短于中期及晚期组,差异有统计学意义(P<0.05)。结论(1)在RMPP患儿中,支气管镜干预疗效显著且安全性高。(2)早期干预支气管镜可缩短患者住院、发热、咳嗽消失时间,促进胸部影像学吸收。
Objective To learn about the clinical efficacy and safety of bronchoscopy intervention at different time points for children with refractory Mycoplasma pneumoniae pneumonia.Methods Retrospective analysis was performed in 142 children with RMPP diagnosed during hospitalization from January 2015 to January 2018,and according to the bronchoscopy intervention time,they were divided into early group(course of disease being 5 to 10 days),mid-term group(11 to 15 days)and late group(16 days or more).Compare the clinical data of three groups of children.Results(1)There were no significant differences in general information,clinical manifestations,inflammatory markers,or chest imaging scores among the three groups before bronchoscopy.(2)The hospitalization time,total fever period,cough disappearance time,and chest imaging absorption time in the early group were shorter than those in the mid-term and late groups(P<0.05).Conclusion(1)Bronchoscopy intervention has a significant effect and safety in the treatment of children with refractory Mycoplasma pneumoniae pneumonia.(2)Early intervention with bronchoscopy can shorten the hospitalization time,reducing the duration of fever and cough,and promote chest imaging absorption.
作者
严秋丽
郝创利
YAN Qiuli;HAO Chuangli(Children's Hospital of Wujiang District,Suzhou 215200,China)
出处
《中国中西医结合儿科学》
2022年第2期138-141,共4页
Chinese Pediatrics of Integrated Traditional and Western Medicine
关键词
难治性肺炎支原体肺炎
支气管镜
影像学
儿童
Refractory Mycoplasma pneumoniae pneumonia
Bronchoscopy
Imaging
Children
